The Competition Commission is to conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, reports News24. “It is important that any possible anti-competitive behaviour, which would push up the price of medication for our people, must be fully investigated,” said DA MP Wilmot James.
The report says Aspen shares dropped after UK reports claimed it had secretly planned to destroy life-saving cancer medicines, as a threat to force countries in Europe to allow price hikes. The company is already in an ongoing legal process with European regulators, as well as a court in Italy. “The DA is concerned that the same practices may have been employed here in South Africa.”
Comment from the Competition Commission was not immediately available, the report said.News24 report